Candesartan Cilexetil
Back to searchMolecule Structure
Scientific Name
Candesartan Cilexetil
Description of the Drug
Candesartan cilexetil is an angiotensin receptor blocker used to treat hypertension, systolic hypertension, left ventricular hypertrophy, and delay progression of diabetic nephropathy.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00796
http://www.drugbank.ca/drugs/DB00796
Brand Name(s)
Amias, Atacand, Candesartan cilexetil, Ratacand
Company Owner(s)
Apotex Inc, Alembic Pharmaceuticals Ltd, Macleods Pharmaceuticals Ltd, Ani Pharmaceuticals Inc, Dr Reddys Laboratories Ltd, Mylan Pharmaceuticals Inc, Zydus Pharmaceuticals Usa Inc, Prinston Pharmaceutical Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Type-1 angiotensin II receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL227 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL40831 | |
| Human Metabolome Database | HMDB0249581 | |
| DrugBank | DB00796 | |
| PubChem: Thomson Pharma | 14887395 | 57582538 |
| PubChem | 2540 | |
| LINCS | LSM-1716 | |
| Nikkaji | J1.640.921I | |
| BindingDB | 50318907 | |
| EPA CompTox Dashboard | DTXSID5020239 | |
| DrugCentral | 475 | |
| ChemicalBook | CB3209325 | |
| Guide to Pharmacology | 8352 | |
| rxnorm | CANDESARTAN CILEXETIL | ATACAND |
| PubChem: Drugs of the Future | 12014669 | |
| ChEBI | 3348 |
